A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety and efficacy of IMM0306 in combination
with lenalidomide in patients with relapsed/refractory CD20-positive B-cell non-Hodgkin
lymphoma.